|Articles|October 1, 2011

Ocriplasmin treats sVMA

Approach achieves positive results in trials

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Latest CME